192 related articles for article (PubMed ID: 37863080)
41. Patient-reported outcomes and their relation with iron parameters in HFE haemochromatosis during maintenance therapy: A prospective cohort study.
Belhomme N; Morcet J; Lescoat A; Robin F; Deugnier Y; Bardou-Jacquet E; Lainé F
Liver Int; 2022 Nov; 42(11):2473-2481. PubMed ID: 35727816
[TBL] [Abstract][Full Text] [Related]
42. Diagnosis and management of genetic haemochromatosis.
Dooley JS
Best Pract Res Clin Haematol; 2002 Jun; 15(2):277-93. PubMed ID: 12401308
[TBL] [Abstract][Full Text] [Related]
43. Correlates of hepcidin and NTBI according to HFE status in patients referred to a liver centre.
Ryan E; Ryan JD; Russell J; Coughlan B; Tjalsma H; Swinkels DW; Stewart S; Crowe JP
Acta Haematol; 2015; 133(2):155-61. PubMed ID: 25277871
[TBL] [Abstract][Full Text] [Related]
44. Effect of phlebotomy on lipid metabolism in subjects with hereditary hemochromatosis.
Casanova-Esteban P; Guiral N; Andrés E; Gonzalvo C; Mateo-Gallego R; Giraldo P; Paramo JA; Civeira F
Metabolism; 2011 Jun; 60(6):830-4. PubMed ID: 20846699
[TBL] [Abstract][Full Text] [Related]
45. Deferasirox in patients with iron overload secondary to hereditary hemochromatosis: results of a 1-yr Phase 2 study.
Cançado R; Melo MR; de Moraes Bastos R; Santos PC; Guerra-Shinohara EM; Chiattone C; Ballas SK
Eur J Haematol; 2015 Dec; 95(6):545-50. PubMed ID: 25684349
[TBL] [Abstract][Full Text] [Related]
46. Magnetic Resonance Liver Iron Concentration Can Guide Venesection Decision-Making in Hyperferritinemia.
Bhuva M; Patterson I; Godfrey EM; Bowden DJ; Griffiths WJH
Dig Dis Sci; 2023 Jun; 68(6):2704-2709. PubMed ID: 36929239
[TBL] [Abstract][Full Text] [Related]
47. John's story - living with hereditary haemochromatosis.
Graham JV; Hogg DR
Rural Remote Health; 2019 May; 19(2):4844. PubMed ID: 31054269
[TBL] [Abstract][Full Text] [Related]
48. MRI-Based Iron Phenotyping and Patient Selection for Next-Generation Sequencing of Non-Homeostatic Iron Regulator Hemochromatosis Genes.
Viveiros A; Schaefer B; Panzer M; Henninger B; Plaikner M; Kremser C; Franke A; Franzenburg S; Hoeppner MP; Stauder R; Janecke A; Tilg H; Zoller H
Hepatology; 2021 Nov; 74(5):2424-2435. PubMed ID: 34048062
[TBL] [Abstract][Full Text] [Related]
49. Patients with hereditary hemochromatosis reach safe range of transferrin saturation sooner with erythrocytaphereses than with phlebotomies.
Rombout-Sestrienkova E; Brandts L; Koek GH; van Deursen CTBM
J Clin Apher; 2022 Feb; 37(1):100-105. PubMed ID: 34897777
[TBL] [Abstract][Full Text] [Related]
50. Hepcidin resistance in dysmetabolic iron overload.
Rametta R; Dongiovanni P; Pelusi S; Francione P; Iuculano F; Borroni V; Fatta E; Castagna A; Girelli D; Fargion S; Valenti L
Liver Int; 2016 Oct; 36(10):1540-8. PubMed ID: 26998752
[TBL] [Abstract][Full Text] [Related]
51. Iron overload in congenital haemolytic anaemias: role of hepcidin and cytokines and predictive value of ferritin and transferrin saturation.
Barcellini W; Zaninoni A; Gregorini AI; Soverini G; Duca L; Fattizzo B; Giannotta JA; Pedrotti P; Vercellati C; Marcello AP; Fermo E; Bianchi P; Cappellini MD
Br J Haematol; 2019 May; 185(3):523-531. PubMed ID: 30828802
[TBL] [Abstract][Full Text] [Related]
52. Hemochromatosis and iron-overload screening in a racially diverse population.
Adams PC; Reboussin DM; Barton JC; McLaren CE; Eckfeldt JH; McLaren GD; Dawkins FW; Acton RT; Harris EL; Gordeuk VR; Leiendecker-Foster C; Speechley M; Snively BM; Holup JL; Thomson E; Sholinsky P;
N Engl J Med; 2005 Apr; 352(17):1769-78. PubMed ID: 15858186
[TBL] [Abstract][Full Text] [Related]
53. Erythrocyte ferritin content in idiopathic haemochromatosis and alcoholic liver disease with iron overload.
Van Der Weyden MB; Fong H; Salem HH; Batey RG; Dudley FJ
Br Med J (Clin Res Ed); 1983 Mar; 286(6367):752-4. PubMed ID: 6402233
[TBL] [Abstract][Full Text] [Related]
54. Hepcidin-guided screen-and-treat interventions for young children with iron-deficiency anaemia in The Gambia: an individually randomised, three-arm, double-blind, controlled, proof-of-concept, non-inferiority trial.
Wegmüller R; Bah A; Kendall L; Goheen MM; Sanyang S; Danso E; Sise EA; Jallow A; Verhoef H; Jallow MW; Wathuo M; Armitage AE; Drakesmith H; Pasricha SR; Cross JH; Cerami C; Prentice AM
Lancet Glob Health; 2023 Jan; 11(1):e105-e116. PubMed ID: 36521942
[TBL] [Abstract][Full Text] [Related]
55. Transient elevation of serum ferritin in a Sri Lankan with homozygosity for H63D mutation in the HFE gene: a case report.
Wickramasinghe W; Karunathilaka C; Jayasinghe S; Gooneratne L
J Med Case Rep; 2020 Jul; 14(1):93. PubMed ID: 32641120
[TBL] [Abstract][Full Text] [Related]
56. Relationships of serum ferritin, transferrin saturation, and HFE mutations and self-reported diabetes in the Hemochromatosis and Iron Overload Screening (HEIRS) study.
Acton RT; Barton JC; Passmore LV; Adams PC; Speechley MR; Dawkins FW; Sholinsky P; Reboussin DM; McLaren GD; Harris EL; Bent TC; Vogt TM; Castro O
Diabetes Care; 2006 Sep; 29(9):2084-9. PubMed ID: 16936157
[TBL] [Abstract][Full Text] [Related]
57. Trientine tetrahydrochloride versus penicillamine for maintenance therapy in Wilson disease (CHELATE): a randomised, open-label, non-inferiority, phase 3 trial.
Schilsky ML; Czlonkowska A; Zuin M; Cassiman D; Twardowschy C; Poujois A; Gondim FAA; Denk G; Cury RG; Ott P; Moore J; Ala A; D'Inca R; Couchonnal-Bedoya E; D'Hollander K; Dubois N; Kamlin COF; Weiss KH;
Lancet Gastroenterol Hepatol; 2022 Dec; 7(12):1092-1102. PubMed ID: 36183738
[TBL] [Abstract][Full Text] [Related]
58. HFE mutations in Caucasian participants of the Hemochromatosis and Iron Overload Screening study with serum ferritin level <1000 µg/L.
Adams PC; McLaren CE; Speechley M; McLaren GD; Barton JC; Eckfeldt JH
Can J Gastroenterol; 2013 Jul; 27(7):390-2. PubMed ID: 23862168
[TBL] [Abstract][Full Text] [Related]
59. Examining the clinical use of hemochromatosis genetic testing.
Lanktree MB; Lanktree BB; Paré G; Waye JS; Sadikovic B; Crowther MA
Can J Gastroenterol Hepatol; 2015; 29(1):41-5. PubMed ID: 25706573
[TBL] [Abstract][Full Text] [Related]
60. HLA haplotype A*03-B*07 in hemochromatosis probands with HFE C282Y homozygosity: frequency disparity in men and women and lack of association with severity of iron overload.
Barton JC; Wiener HW; Acton RT; Go RC
Blood Cells Mol Dis; 2005; 34(1):38-47. PubMed ID: 15607698
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
